237 related articles for article (PubMed ID: 9128965)
21. Differential effects of CLDR and PDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumour model.
Harms W; Weber KJ; Ehemann V; Zuna I; Debus J; Peschke P
Int J Radiat Biol; 2006 Mar; 82(3):191-6. PubMed ID: 16638716
[TBL] [Abstract][Full Text] [Related]
22. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngenic rat prostate tumour model.
Harms W; Peschke P; Weber KJ; Hensley FW; Wolber G; Debus J; Wannenmacher M
Int J Radiat Biol; 2002 Jul; 78(7):617-23. PubMed ID: 12079541
[TBL] [Abstract][Full Text] [Related]
24. Why shorter half-times of repair lead to greater damage in pulsed brachytherapy.
Fowler JF
Int J Radiat Oncol Biol Phys; 1993 May; 26(2):353-6. PubMed ID: 8491693
[TBL] [Abstract][Full Text] [Related]
25. Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols.
Brenner DJ; Hall EJ; Huang Y; Sachs RK
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):893-901. PubMed ID: 8040040
[TBL] [Abstract][Full Text] [Related]
26. [The initial results on the radiobiological comparability of continuous LDR irradiation and PDR irradiation using a guinea pig skin animal model].
Brock A; Prager W; Pohlmann S; Friedrich K
Strahlenther Onkol; 1995 Nov; 171(11):641-5. PubMed ID: 7502227
[TBL] [Abstract][Full Text] [Related]
27. Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the cervix.
Fowler JF
Radiother Oncol; 1997 Oct; 45(1):49-54. PubMed ID: 9364631
[TBL] [Abstract][Full Text] [Related]
28. Time resolved dose rate distributions in brachytherapy.
Peppa V; Pappas EP; Karaiskos P; Papagiannis P
Phys Med; 2017 Sep; 41():13-19. PubMed ID: 28457787
[TBL] [Abstract][Full Text] [Related]
29. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
30. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.
Haddad A; Peiffert D; Lapeyre M; Harter V; Buchheit I; Graff P
Brachytherapy; 2014; 13(6):597-602. PubMed ID: 24913434
[TBL] [Abstract][Full Text] [Related]
31. Radiobiological responses for two cell lines following continuous low dose-rate (CLDR) and pulsed dose rate (PDR) brachytherapy.
Hanisch PH; Furre T; Olsen DR; Pettersen EO
Acta Oncol; 2007; 46(5):602-11. PubMed ID: 17562436
[TBL] [Abstract][Full Text] [Related]
32. Quantitative comparisons of continuous and pulsed low dose rate regimens in a model late-effect system.
Brenner DJ; Hall EJ; Randers-Pehrson G; Huang Y; Johnson GW; Miller RW; Wu B; Vazquez ME; Medvedovsky C; Worgul BV
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):905-10. PubMed ID: 8598369
[TBL] [Abstract][Full Text] [Related]
33. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
34. Pulsed dose rate brachytherapy in head and neck cancers. Feasibility study of a French cooperative group.
Peiffert D; Castelain B; Thomas L; Ardiet JM; Baillet F; Mazeron JJ
Radiother Oncol; 2001 Jan; 58(1):71-5. PubMed ID: 11165684
[TBL] [Abstract][Full Text] [Related]
35. High-dose-rate and pulsed-dose-rate brachytherapy for oral cavity cancer and oropharynx cancer.
Polo A
J Contemp Brachytherapy; 2009 Dec; 1(4):216-223. PubMed ID: 28050175
[TBL] [Abstract][Full Text] [Related]
36. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
37. Radiobiological aspects of continuous low dose-rate irradiation and fractionated high dose-rate irradiation.
Turesson I
Radiother Oncol; 1990 Sep; 19(1):1-15. PubMed ID: 2236638
[TBL] [Abstract][Full Text] [Related]
38. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
39. Pulsed brachytherapy: a formalism to account for the variation in dose rate of the stepping source.
Narayana V; Orton CG
Med Phys; 1999 Feb; 26(2):161-5. PubMed ID: 10076968
[TBL] [Abstract][Full Text] [Related]
40. Pulsed brachytherapy as a substitute for continuous low dose rate: an in vitro study with human carcinoma cells.
Chen CZ; Huang Y; Hall EJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):137-43. PubMed ID: 9054889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
